Bydureon officially hits market

Amylin Pharmaceuticals and Alkermes announced that their Type 2 diabetes treatment now is available by prescription in U.S. pharmacies.

Want to Read More?

This content is available only to registered users. Log in to read the rest of this article or create a free account.

© 2012 Drug Store News. All Rights Reserved.